Carotid Artery Stent Placement and Carotid Endarterectomy: A Challenge for Urgent Treatment after Stroke-Early and 12-Month Outcomes in a Comprehensive Stroke Center

Autor: Arnaldo Ippoliti, Nicola Toschi, Jacopo M. Legramante, Alessandro Rocco, Marina Diomedi, Roberto Gandini, Enrico Pampana, Barbara Rizzato, Andrea Ascoli Marchetti, Fabrizio Sallustio
Rok vydání: 2017
Předmět:
Male
medicine.medical_specialty
Time Factors
medicine.medical_treatment
Carotid endarterectomy
030204 cardiovascular system & hematology
Settore MED/22 - Chirurgia Vascolare
03 medical and health sciences
0302 clinical medicine
Modified Rankin Scale
Recurrence
Risk Factors
Internal medicine
medicine.artery
medicine
Secondary Prevention
Humans
Radiology
Nuclear Medicine and imaging

Carotid Stenosis
cardiovascular diseases
Stroke
Endarterectomy
Aged
Retrospective Studies
Aged
80 and over

Endarterectomy
Carotid

business.industry
Endovascular Procedures
Stent
Settore MED/37 - Neuroradiologia
Retrospective cohort study
Middle Aged
medicine.disease
Stenosis
Treatment Outcome
Ischemic Attack
Transient

Cardiology
Feasibility Studies
Settore MED/26 - Neurologia
Female
Stents
Internal carotid artery
Cardiology and Cardiovascular Medicine
business
030217 neurology & neurosurgery
Zdroj: Journal of vascular and interventional radiology : JVIR. 29(9)
ISSN: 1535-7732
Popis: To compare feasibility, 12-month outcome, and periprocedural and postprocedural risks between carotid artery stent (CAS) placement and carotid endarterectomy (CEA) performed within 1 week after transient ischemic attack (TIA) or mild to severe stroke onset in a single comprehensive stroke center.Retrospective analysis of prospective data collected from 1,148 patients with ischemic stroke admitted to a single stroke unit between January 2013 and July 2015 was conducted. Among 130 consecutive patients with symptomatic carotid stenosis, 110 (10 with TIA, 100 with stroke) with a National Institutes of Health Stroke Scale (NIHSS) score20 and a prestroke modified Rankin Scale (mRS) score2 were eligible for CAS placement or CEA and treated according to the preference of the patient or a surrogate. Periprocedural (48 h) and postprocedural complications, functional outcome, stroke, and death rate up to 12 months were analyzed.Sixty-two patients were treated with CAS placement and 48 were treated with CEA. Several patients presented with moderate or major stroke (45.8% CEA, 64.5% CAS). NIHSS scores indicated slightly greater severity at onset in patients treated with a CAS vs CEA (6.6 ± 5.7 vs 4.2 ± 3.4; P = .08). Complication rates were similar between groups. mRS scores showed a significant improvement over time and a significant interaction with age in both groups. Similar incidences of death or stroke were shown on survival analysis. A subanalysis in patients with NIHSS scores ≥ 4 showed no differences in complication rate and outcome.CAS placement and CEA seem to offer early safe and feasible secondary stroke prevention treatments in experienced centers, even after major atherosclerotic stroke.
Databáze: OpenAIRE